Prenetics Global Limited has completed the divestiture of its 35% stake in Insighta to technology conglomerate Tencent for $70 million in cash proceeds. The transaction significantly strengthens the company's financial position, bringing total adjusted liquidity to $171.1 million while maintaining a debt-free balance sheet.
The Hong Kong-based wellness and diagnostics company intends to deploy the capital toward accelerating the international expansion of IM8, a consumer health platform developed in partnership with footballer David Beckham. IM8 has demonstrated rapid market adoption, generating over $100 million in annualized recurring revenue within its first 11 months of operations and establishing a presence across more than 30 countries.
The Insighta divestment represents a strategic capital allocation decision for Prenetics, allowing the company to concentrate resources on its higher-growth IM8 platform. The sale reflects confidence in the platform's market trajectory and underscores Tencent's continued investment appetite in health technology ventures.